Insulet (NSDQ:PODD) said today that it inked a deal with Glooko to connect data from Insulet’s Omnipod insulin delivery devices in Europe with the Glooko+diasend diabetes data management system. Glooko touted that its data management tech is used at roughly 7,000 provider sites across 23 countries. The Glooko+diasend system allows users to sync and review data from an […]
Senseonics inks diabetes management deal with Glooko
Senseonics (NYSE:SENS) said today that it inked a global deal to integrate its Eversense continuous glucose monitoring system with Glooko‘s diabetes data management tech. Users will be able to sync data from their Eversense CGM directly into Glooko’s platform and view historical glucose trends, as well as receive real-time readings from their Eversense mobile app, according to […]
Glooko launches next-gen diabetes web analytics platform
Glooko said today it launched a new version of its web application, including updates to its navigation and diabetes analytics, charts and graphic capabilities. The Mountain View, Calif.-based company said the update was the result of over a year of research and development exploring “the most insightful analytics features” within its platforms. Read the whole […]
Glooko names digital health veteran as CEO | Personnel Moves – April 17, 2018
Glooko named health tech veteran Russ Johannesson as its new chief executive this month, adding that the diabetes data management company’s former CEO, Rick Altinger, is slated to become EVP of corporate development. Johannesson previously served as the chief operating officer of Sharecare, a digital health and wellness platform. Before that he led sales, marketing and […]
Meet the insulin-makers and device companies developing smart insulin pens
The global market for connected insulin pens could be worth up to $123 million by 2023, according to a report published this year by Research & Markets. Insulin pens, designed for people who control their diabetes with multiple daily injections instead of a pump or wearable patch, are portable devices that were first introduced in 1985 with […]
Glooko touts patient outcomes for remote diabetes care tech
Glooko touted data today from a six-month pilot program that evaluated the company’s remote diabetes management technology for people with Type II diabetes. The pilot, which spanned from April until October of 2016, involved 50 Type II diabetes patients from San Diego, Calif.-based Sharp Rees-Stealy Medical Group. The medical group evaluated patient engagement, A1c levels, LDL, […]
DreaMed Diabetes wins CE Mark for insulin therapy management platform
DreaMed Diabetes has won CE Mark clearance for its Advisor Pro decision-support platform, designed to help healthcare professionals manage insulin therapy for their Type I diabetes patients. The company’s cloud-based platform provides personalized insulin treatment plans by combining data from insulin pumps and continuous glucose monitors. Using machine learning techniques, the system analyzes all of the […]
Glooko wins FDA nod for mobile insulin dosing system
The FDA has approved Glooko‘s mobile insulin dosing system, which is designed to titrate long-acting insulin for people with Type II diabetes. The company’s system accesses blood glucose data directly from the user’s glucose meter so that the user doesn’t have to manually enter their fasting glucose values. Then, it analyzes those levels to recommend insulin […]
Study: Glooko’s mobile app boosts glycemic control in patients with Type II diabetes
Glooko touted data today from a feasibility study evaluating the impact of its mobile insulin dosing system for people with Type II diabetes who are taking long-acting insulin. The Mountain View, Calif.-based company said it hoped to better understand the extent to which its system can make appropriate insulin titration adjustments and improve a patient’s glycemic […]
Novo Nordisk, Glooko launch joint C4C diabetes management app
Novo Nordisk (NYSE:NVO) and Glooko said today they jointly launched the Cornerstones4Care mobile application designed to aid individuals in managing their diabetes. The C4C application integrates Novo Nordisk’s diabetes knowledge and personalized patient support with Glooko’s digital platform and data analytics, the companies said, and is the 1st jointly developed product from the pair, which announced […]
Insulet, Mayo Clinic get in on Glooko’s $35m Series C round
Insulet (NSDQ:PODD) and Mayo Clinic were among the new investors to get in on a $35 million Series C round for Glooko and its diabetes management platform. The round was led by new investor Georgian Partners, joined by Insulet and Mayo Clinic and existing backers Medtronic, Samsung, Canaan Partners and Social Capital, Mountain View, Calif.-based Glooko said. The […]
MassDevice Network
@MassDevice
LinkedIn
YouTube